InsiderTrades

Form 4 for AGL agilon health, inc.

Accepted 2022-07-11 00:00:00 ET · period of report 2022-07-07 · accession 0001209191-22-041801 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-07-11 2022-07-07 AGL Desai Veeral Chief Strategy, Dev. Off S - Sale+OE $25.00 -319.1K 278.2K -53% -$7.98M
D 2022-07-11 2022-07-07 AGL Desai Veeral Chief Strategy, Dev. Off M - OptEx $1.00 +319.1K 597.3K +115% +$319.1K
D 2022-07-11 2022-07-07 AGL Desai Veeral Chief Strategy, Dev. Off M - OptEx $0.00 -319.1K 137.2K -70% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-07 S D 319,071 $25.00 278,211 D — — (F1) Includes restricted stock units.
2 Common Common Stock 2022-07-07 M A 319,071 $1.00 597,282 D — — (F1) Includes restricted stock units.
3 Derivative Options (Rights to Buy) 2022-07-07 M D 319,071 $0.00 137,209 D $1.00 · — to 2027-04-27 319,071 Common Stock (F3) These options were granted on April 27, 2017 and fully vested on April 27, 2021.